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Abstract
Long-term cancer survivors are at increased risk for the development of second primary malignancies. This is usually asso-
ciated with common genetic and etiologic factors and the treatment modality used for the primary cancer. In this paper we
describe the case of a patient who developed a leiomyosarcoma in his left arm 5 years after he had a colon adenocarcinoma
resected. Both primary tumours were treated successfully with surgical resection alone. The literature regarding second
primary neoplasms, specifically focused on sarcomas, is briefly reviewed.
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Introduction
Second primary malignancies can develop after suc-
cessful treatment of malignant neoplasms.1 Occur-
rence  of  second malignancies  has  been  associated
with  common  etiologic  factors  implicated  in  the
development of a first cancer, or with the treatment
modality used for the primary cancer.2,3 However, in
many  cases,  such  a  relationship  fails  to  be  docu-
mented.4 We present in this paper the case of a leio-
myosarcoma  that  occurred  5  years  following  the
resection a colon cancer. To our knowledge, this is
the first report of such an occurrence. 
Case report
A 70-year-old male had a right hemicolectomy for a
colon adenocarcinoma at the age of 65. Histological
examination revealed a colon adenocarcinoma pene-
trating to the subserosa (Dukes’ stage B) arising from
a villous adenoma. The patient was not offered adju-
vant  chemotherapy but  was  only put  on a  regular
follow-up consisting of clinical examination and lab-
oratory evaluation every 6 months and colonoscopy
every 2 years. Five years later, he developed a lump,
gradually increasing in size, in his left arm. The swell-
ing was located at the posterolateral surface of the
upper third of his left arm and measured approxi-
mately  5  x 6  cm2  when  he  was  seen  in  clinics 4
months later  (Fig.  1).  The  mass  was  hard,  firmly
attached to the surrounding tissues and mildly pain-
ful at palpation, and the overlying skin was warm and
Fig. 1. A magnetic resonance T1-weighted image showing a
well-defined solid tumour  with slightly hyperintense periphery
and hypointense centre, in contact with the deltoid and the triceps
muscles, that was histologically proven to be a grade III leimy
osarcoma.32 A. Mavrodontidis et al.
erythematous.  The  patient  had  a  temperature  of
37.5mC. Dynamic contrast-enhanced perfusion mag-
netic  resonance  imaging  disclosed  a  well-defined
solid tumour measuring 5 x 5.5 x 4.5 cm3, slightly
hyperintense  in  the  periphery  with  hypointense
patches in the centre on T1-weighted images (Fig. 1),
and highly hyperintense on T2-weighted images. The
tumour was located by the deltoid muscle and in con-
tact with the triceps, and with indications of possible
infiltration of the subcutaneous fat and the long and
lateral heads of the triceps muscle. Staging computed
tomography  scans  of  thorax  and  abdomen  was
proven  negative  for  metastases.  The  tumour  was
widely excised together with the surrounding soft tis-
sues and overlying skin, and with part of the deltoid
and of the long and lateral heads of the triceps. A split
thickness skin graft was used to cover the resulting
skin defect. Microscopic examination showed a spin-
dle cell sarcoma composed of short fascicles of cells,
most of which had perinuclear vacuoles and/or clot-
ted appearance of cytoplasm (Fig 2). Mitotic figures
exceeded a number of 50 per 10 high power fields (x
40) and the extent of necrosis reached 30% of the
tumor volume. Immunohistochemistry performed on
paraffin  sections  detected  strong  expression  of
vimentin,  muscle-specific  actin  (HHF35)  in  most
neoplastic  cells,  while  desmin  was  only  focally
expressed. EMA, Cytokeratins,  S100  protein,  and
CD34 were all negative. Based on the morphological
and immunohistochemical findings, the diagnosis of
a  grade  III  leiomyosarcoma  was  given.  Resection
margins were tumour free at a minimum of > 2 cm.
No  adjuvant  therapy  was  administered  and  the
patient remains disease-free 3 years after the sarcoma
resection. One year following the sarcoma diagnosis,
his brother died of oesophageal carcinoma at the age
of 67.
Discussion
Long-term cancer survivors are at increased risk for
the development of second malignancies. The occur-
rence of a second metachronous primary malignancy
may reflect an underlying genetic or immunological
defect in the patient, environmental exposure to car-
cinogens or a complication of treatment modalities
used in the management of the primary tumour.1 
Radiotherapy has been associated with increased
incidence of second malignancies, especially sarco-
mas.  Post-irradiation  sarcomas  arise  within  areas
exposed  to  prior  irradiation.  Of  these,  malignant
fibrous histiocytoma is asas the most common histo-
logical type in adults,5,6 while paediatric patients who
received more than 6000 rad to the bone in childhood
have a 40-fold increased risk for bone cancer.7
Chemotherapy-induced  malignancies  have  been
consistently reported in patients treated with alkylat-
ing agents in the past. Large increases in the inci-
dence of leukaemia and non-Hodgkin’s lymphomas,
during the early years after treatment, and of solid
tumours  in  the  long-term  have  particularly  been
demonstrated in patients  with  Hodgkin’s  disease.8
Smoking is another well known common factor to the
development of a second primary in cancer survivors,
with an overall cumulative risk of a second primary
lung cancer of 4.7% and any tobacco-related tumor
Fig. 2. Photomicrograph of a tumour section adjacent to central necrosis. Spindle-shaped neoplastic cells are firmly packed and most 
of them have clear cytoplasm (H & E, x 300)Leiomyosarcoma as a second primary neoplasm 33
of 11% at 10 years.9 Second primary malignancies
may also occur in the absence of recognizable etio-
logic or triggering factors. A 5% incidence of second
primary neoplasms other than melanoma was found
at  5  years  in  malignant  melanoma  survivors  who
received only surgical treatment,10 while a moder-
ately increased risk for the developing of meningioma
was found in colorectal cancer surviving patients.11
Genetic susceptibility for the development of non-
treatment-related  metachronous  second  primary
malignancies is well known in definite tumour types
such as retinoblastoma and Wilm’s tumour, and is
strongly suggested in patients with a family history of
malignant  neoplasms,  especially  at  young  ages.  A
small group of these patients has been shown to carry
germ line mutations to the p53 gene.12,13
Second primary sarcomas are most often unrelated
to irradiation, although they are commonly perceived
as a late sequel of irradiation. Robinson et al. presented
the clinical characteristics of  240  patients  with  sar-
coma as a second metachronous primary neoplasm
registered during the period 1973± 1986 in the Surveil-
lance, Epidemiology and End Results (SEER) Pro-
gram in the United States. Only 30% of this group of
patients  had  a  post-irradiation  sarcoma,  while  the
others developed the sarcoma in an area not previously
exposed to radiotherapy. In the SEER Program, the
survival of patients with sarcoma as a second tumour
was significantly worse in comparison with single sar-
comas.14 Sarcomas constitute the most common type
of second malignant neoplasms in patients with a his-
tory of bilateral retinoblastoma, while bone tumours
are ranked high in rate among second primary malig-
nancies in patients with a history of Hodgkin’s dis-
ease.8,15  Furthermore,  an  increased  incidence  of
Classic Kaposi’s sarcoma was detected following diag-
nosis of lymphomas and breast cancer,16 and of post-
irradiation soft tissue sarcomas in patients with a his-
tory of testicular cancer.17
We conclude that, besides being the first report of
a soft tissue sarcoma that occurs as a second meta-
chronous neoplasm, following colorectal carcinoma,
this case illustrates the worthiness of increased aware-
ness for early diagnosis of a second primary malig-
nancy in long-lasting disease-free survivors. Efforts
for early detection and surgical treatment of second-
ary primary neoplasms may further improve progno-
sis in cancer patients. 
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